Clinical Trials Logo

Citation(s)

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients: Defining Optimal Combinations and Determinants of Immunological Response

Details for clinical trial NCT04205552